This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CHONDROSARCOMA_EXALLC for full statistics.
Chondrosarcoma
C3_CHONDROSARCOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
103 |
4. Check minimum number of eventsNone |
103 |
5. Include endpointsNone |
103 |
6. Filter based on genotype QC (FinnGen only) |
103 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Chondrosarcoma
based on the number of shared cases.
Similar with more cases:
- Chondrosarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 103 | 45 | 58 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 55.82 | 54.39 | 56.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 94
- Matched controls
- 937
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
58.8
25.4
29
7
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
25.1
23
*
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
24.0
22
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
16.1
15
*
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
15.0
14
*
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
15.0
14
*
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
13.9
13
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.2
12.0
47
151
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
11.7
11
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
+∞
11.7
11
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
123.2
10.7
11
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.6
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.1
9.6
61
294
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
9.5
9
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
98.5
8.6
9
*
NF3AA
NOMESCO Finland
Femur X-ray examination
36.9
8.3
10
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.4
7.9
17
24
C32.3
ICD-10 Finland
Malignant neoplasm: Laryngeal cartilage
+∞
7.4
7
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
7.4
7
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
7.4
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.4
7
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.3
6.9
18
34
GBB00
NOMESCO Finland
Tracheostomy
43.3
6.9
8
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
43.3
6.9
8
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
24.6
6.8
9
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
5.2
6.8
21
49
B01AB05
ATC
enoxaparin; parenteral
3.2
6.6
43
194
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
74.7
6.5
7
*
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
74.7
6.5
7
*
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
6.3
6
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
6.3
6
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
6.3
6
*
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
+∞
6.3
6
*
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
6.3
6
*
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
42
201
2.84
5.99
2.7
2.7
—
—
—
0
0
64
384
2.76
5.83
4.0
4.2
—
—
—
0
0
24
102
2.76
4.12
6.3
6.3
0.5
1.3
mmol/l
0.61
19
81
54
384
1.85
2.43
5.5
6.1
1.2
1.2
mmol/l
0.77
48
349
7
18
4.09
2.29
1.0
1.4
—
—
—
0
0
7
18
4.09
2.29
1.0
1.4
—
—
—
0
0
64
499
1.75
1.96
7.3
10.0
3.8
4.3
e9/l
1.25
57
451
18
96
2.06
1.85
2.1
4.6
1.9
124.9
ug/l
0.88
13
81
55
424
1.64
1.66
6.0
6.9
1.2
1.2
mmol/l
0.58
47
360
65
525
1.65
1.61
5.1
4.6
6.5
6.7
mmol/l
0.47
58
485
18
102
1.93
1.57
2.1
2.7
4.2
7.2
umol/l
1.55
18
87
68
784
0.61
1.49
6.3
6.3
39.3
41.0
mmol/mol
0.67
58
731
6
22
2.83
1.45
1.5
1.5
—
—
—
0
0
15
82
1.97
1.45
2.5
4.4
—
—
—
0
0
10
48
2.20
1.32
8.5
6.3
24.1
24.5
mmol/l
—
10
48
19
119
1.73
1.22
2.3
5.7
1.0
1.0
mmol/l
0.38
19
111
91
827
1.86
1.20
18.0
15.5
31.3
24.6
mg/l
1.12
79
662
0
36
0.00
1.16
0.0
1.1
—
—
—
0
0
5
22
2.34
1.04
1.8
1.1
353.8
3.4
e6/l
—
5
17
5
22
2.34
1.04
1.8
1.3
351.8
497.4
e6/l
—
5
17
9
50
1.88
0.99
2.4
3.4
2.0
1.8
mmol/l
—
9
37
5
24
2.14
0.75
1.6
1.3
—
—
—
0
0
15
103
1.53
0.70
1.7
1.7
—
—
—
0
0
78
836
0.72
0.64
4.4
5.3
2.5
2.6
mmol/l
1.26
65
759
76
817
0.73
0.63
4.0
4.7
4.4
4.5
mmol/l
0.81
65
748
15
106
1.49
0.62
4.1
4.7
230.8
249.1
u/l
0.25
15
100
16
115
1.46
0.61
4.4
4.8
33.6
30.2
%
—
10
72
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
15
107
1.47
0.59
1.7
1.8
—
—
—
0
0
8
54
1.52
0.59
2.3
1.7
—
—
—
0
0
92
873
1.50
0.56
21.0
17.7
3.9
4.0
mmol/l
1.13
87
843
6
37
1.66
0.56
2.0
4.3
22.1
254.8
mg/l
—
6
29
75
804
0.75
0.56
4.3
4.9
5.8
6.0
mmol/l
0.90
62
729
76
813
0.75
0.56
4.2
4.7
1.5
1.5
mmol/l
0.07
64
739
15
111
1.41
0.50
1.4
1.4
—
—
—
0
0
93
889
1.48
0.49
22.2
18.3
74.8
81.1
umol/l
1.72
93
889
19
149
1.34
0.46
2.2
3.4
0.8
0.8
mmol/l
0.08
19
142
93
891
1.45
0.45
11.6
11.0
26.2
25.6
u/l
0.14
87
855
30
252
1.27
0.45
3.8
2.9
33.5
33.1
u/l
0.02
30
241
5
33
1.54
0.42
1.4
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
6
45
1.35
0.34
2.5
2.4
—
—
—
0
0
75
786
0.83
0.30
3.6
4.2
1.1
1.3
mmol/l
1.72
64
714
7
56
1.27
0.30
1.4
1.4
—
—
—
0
0
18
150
1.24
0.29
1.8
1.9
—
—
—
0
0
5
70
0.70
0.27
2.2
4.9
1.2
1.2
mmol/l
—
5
64
51
548
0.86
0.27
2.6
2.9
42.6
48.9
u/l
0.44
45
509
9
73
1.25
0.26
1.4
1.9
—
—
—
0
0
5
37
1.37
0.24
2.2
4.4
17.6
30.0
mg/l
—
5
29
5
37
1.37
0.24
1.4
2.0
—
—
—
0
0
8
100
0.78
0.22
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
3.3
—
0
5
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
39
360
1.13
0.20
1.8
2.0
88.4
92.9
pmol/l
0.21
20
178
82
796
1.15
0.17
17.7
14.8
84.3
77.9
ml/min/173m2
1.66
69
654
16
182
0.86
0.17
1.4
1.7
1257.9
1256.1
nmol/l
—
9
137
25
228
1.13
0.15
5.8
4.4
0.0
0.0
estimate
0.00
11
80
78
758
1.12
0.14
4.7
4.5
2.0
2.0
mu/l
0.14
66
674
27
292
0.90
0.14
4.9
4.4
20.3
21.3
%
0.14
14
147
15
169
0.87
0.14
1.1
1.3
1.5
1.1
u/ml
—
5
49
13
114
1.16
0.12
6.2
7.9
—
—
—
0
0
33
348
0.92
0.09
4.0
4.2
27.5
50.9
ng/l
0.77
25
257
6
56
1.08
0.09
1.7
1.8
—
—
—
0
0
7
64
1.10
0.08
1.6
2.0
433.3
144.7
ng/l
—
7
54
7
64
1.10
0.08
1.6
1.8
—
—
—
0
0
34
325
1.07
0.07
5.3
4.1
—
—
—
0
0
13
142
0.90
0.07
2.0
3.0
4.8
2.2
e6/l
—
5
85
40
413
0.95
0.05
4.8
3.9
0.0
0.0
estimate
—
10
80
26
272
0.94
0.05
2.2
3.4
1955.2
1387.8
ng/l
0.15
21
227
46
472
0.95
0.04
3.7
2.6
—
—
—
0
0
40
411
0.96
0.04
5.7
5.2
0.0
0.0
estimate
—
10
82
23
240
0.95
0.04
2.3
3.1
0.3
0.5
e6/l
0.53
17
183
21
218
0.95
0.02
2.6
2.9
1.2
0.8
ug/l
0.91
16
147
40
407
0.97
0.01
4.8
3.9
0.0
0.0
estimate
0.00
11
87
59
592
0.99
0.00
4.4
3.9
14.2
14.9
pmol/l
1.17
51
527
31
315
0.98
0.00
2.6
3.4
—
—
—
0
0
15
149
1.01
0.00
1.9
2.8
0.5
0.9
e6/l
—
7
91
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
8
87
0.91
0.00
2.6
2.2
318.4
379.0
nmol/l
—
8
79
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
4.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CHONDROSARCOMA – Chondrosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).